1. Home
  2. ZNTL vs IRBT Comparison

ZNTL vs IRBT Comparison

Compare ZNTL & IRBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZNTL
  • IRBT
  • Stock Information
  • Founded
  • ZNTL 2014
  • IRBT 1990
  • Country
  • ZNTL United States
  • IRBT United States
  • Employees
  • ZNTL N/A
  • IRBT N/A
  • Industry
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • IRBT Consumer Electronics/Appliances
  • Sector
  • ZNTL Health Care
  • IRBT Consumer Discretionary
  • Exchange
  • ZNTL Nasdaq
  • IRBT Nasdaq
  • Market Cap
  • ZNTL 227.0M
  • IRBT 253.6M
  • IPO Year
  • ZNTL 2020
  • IRBT N/A
  • Fundamental
  • Price
  • ZNTL $2.25
  • IRBT $7.79
  • Analyst Decision
  • ZNTL Buy
  • IRBT Hold
  • Analyst Count
  • ZNTL 8
  • IRBT 2
  • Target Price
  • ZNTL $10.50
  • IRBT $13.00
  • AVG Volume (30 Days)
  • ZNTL 1.6M
  • IRBT 2.1M
  • Earning Date
  • ZNTL 02-25-2025
  • IRBT 02-24-2025
  • Dividend Yield
  • ZNTL N/A
  • IRBT N/A
  • EPS Growth
  • ZNTL N/A
  • IRBT N/A
  • EPS
  • ZNTL N/A
  • IRBT N/A
  • Revenue
  • ZNTL $40,560,000.00
  • IRBT $817,355,000.00
  • Revenue This Year
  • ZNTL N/A
  • IRBT N/A
  • Revenue Next Year
  • ZNTL N/A
  • IRBT N/A
  • P/E Ratio
  • ZNTL N/A
  • IRBT N/A
  • Revenue Growth
  • ZNTL N/A
  • IRBT N/A
  • 52 Week Low
  • ZNTL $2.16
  • IRBT $5.83
  • 52 Week High
  • ZNTL $18.07
  • IRBT $19.68
  • Technical
  • Relative Strength Index (RSI)
  • ZNTL 32.94
  • IRBT 44.14
  • Support Level
  • ZNTL $2.16
  • IRBT $8.09
  • Resistance Level
  • ZNTL $2.93
  • IRBT $9.66
  • Average True Range (ATR)
  • ZNTL 0.28
  • IRBT 1.13
  • MACD
  • ZNTL -0.07
  • IRBT -0.21
  • Stochastic Oscillator
  • ZNTL 7.69
  • IRBT 5.11

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

About IRBT iRobot Corporation

iRobot Corp is a united state based consumer robot company. It designs and builds robots that assist consumers with the solutions for the activities to be carried both inside and outside of the home. The company's consumer robot comprises a portfolio of solutions which includes cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company operates in the business segment of Consumer robots. The consumer robot products are provided to the consumers by retail businesses and online store. The company derives its revenue from the product sales. It sells the products across the United States and around the world.

Share on Social Networks: